The new PhenoImager Fusion system brings the latest advances in multiplex imaging enabling whole-slide, multispectral imaging (MSI) at single-cell resolution at unprecedented speed (6 biomarkers per slide in under 20 minutes). Together with our high-throughput PhenoImager HT, these instruments are the fastest quantitative digital pathology imaging platforms enabling rapid and accurate spatial phenotyping at scale. You’ll also get a sneak peek at new spatial signature panels powered by a novel, universal chemistry that allows you to move seamlessly from high-plex spatial phenotyping assays for discovery on the PhenoCycler-Fusion to validate the resulting biomarkers on the Fusion, as a standalone system, at a capacity of 100+ samples per week.
What you will learn
- How the PhenoImager Fusion enables the development of more relevant and highly predictive biomarkers, called spatial phenotypic signatures
- How Multispectral Imaging (MSI) technology leads to quantitative and accurate phenotyping
- How our universal antibody chemistry promotes a seamless continuum from Discovery to Translational Research
Related Posts
Accelerate Building Custom Spatial Proteomic Panels for New Biological Insights
Ultrasensitive Neuroimmune Biomarker Measurement for Translational Research and Therapeutic Development
Underdiagnosis of Alzheimer’s disease pathology in patients with cardiovascular disease
Decoding Neurodegeneration: High-plex Spatial Proteomics Reveal Distinct Cell Phenotypes and Pathological Signatures in Parkinson’s and Alzheimer’s Disease
In this webinar, Dr. Birgitt Schuele, Associate Professor (Research) of Pathology at Stanford University, showcases how ultrahigh-plex spatial proteomics is being used to uncover distinct cell phenotypes and pathological signatures…
Understanding the Brain: Advancing Neurodegeneration Research with Ultrahigh-Plex Spatial Proteomics
In this webinar, learn how ultrahigh-plex spatial phenotyping has been applied to neurodegenerative disease research.
p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer’s Disease Research
Spatial Awareness: AI-powered Profiling of Trillions of Immune Cell Distribution Data Points Reveals Key Predictors of Cancer Recurrence Risk
This webinar highlights a groundbreaking study recently published as a Nature cover story (April 2025). Dr. Joe Yeong will describe how a pre-designed analytical framework—driven by well-defined clinical and scientific…
Multimodal Single-Cell Spatial Transcriptomics and Proteomics to Uncover the Biological Processes Driving Immunotherapy Response and Resistance in Renal Cancer
In this webinar, Dr. Anne-Laure Cattin from the Cancer Dynamics Laboratory at The Francis Crick Institute in London, will share her research on kidney cancer, focusing on the integration of…